Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant Depression
People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
What to Know About the New Nasal Spray for Tough Depression
CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more medication.
J&J's ketamine-derived nasal spray approved by FDA to treat depression
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.
Can a Nasal Spray Really Help Treat Depression? Here's What to Know About Spravato
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
US FDA Approves First Of Its Kind Ketamine-Based Nasal Spray To Treat Depression: Know All About This Drug
The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for treatment-resistant depression.
Ketamine-Derived Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
FDA-approved nasal spray for severe depression can lead to remission
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in people who have not responded to at least two oral antidepressants.
Low-dose oral ketamine shows promise in treating PTSD symptoms
A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...
Colorado clinic looking to help patients with ketamine-assisted psychotherapy
The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a ...
Tampa Free Press on MSN6d
How Ketamine Therapy Helps With Depression And PTSD
Exploring new treatment avenues has become crucial as mental health challenges such as depression and PTSD continue impacting ...
Research indicates recreational ketamine use is on the rise
Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...
Daily Camera23h
Boulder Community Health now offering ketamine therapy, other therapies for treatment-resistant conditions
Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...
Adult star Emily Willis 'permanently disabled' after rehab stint for 'ketamine addiction'
It has been claimed that former adult star Emily Willis, 25, is now "permanently disabled" and in a semi-conscious state ...
Impacts1d
Fast-Acting Anxiety Relief: How Ketamine Works on the Brain
Why We Need Fast-Acting Anxiety Relief Now More Than Ever Anxiety isn’t just feeling nervous before a big event—it can be relentless, overwhelming, and even debilitating. Traditional treatments like ...
soapcentral6d
What was Matthew Perry's cause of death?
Actor Matthew Langford Perry was born on August 19, 1969, and died on October 28, 2023. His role as Chandler Bing on the NBC comedy Friends (1994–2004) brought him international recognition.